{
  "id": "1e203a832474182a",
  "title": "Biocon Moves to Fully Own Biologics Unit Valued at $5.5 Billion",
  "description": "Indian pharmaceuticals firm Biocon Ltd. will buy out minority shareholders in Biocon Biologics Ltd. via a mix of cash and shares in a deal that values the biosimilars unit at $5.5 billion.",
  "content": "Indian pharmaceuticals firm Biocon Ltd. will buy out minority shareholders in Biocon Biologics Ltd. via a mix of cash and shares in a deal that values the biosimilars unit at $5.5 billion.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/articles/2025-12-06/biocon-moves-to-fully-own-biologics-unit-valued-at-5-5-billion",
  "published_at": "2025-12-06T10:38:23+00:00",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "Biocon Moves to Fully Own Biologics Unit Valued at $5.5 Billion",
    "description": "Indian pharmaceuticals firm Biocon Ltd. will buy out minority shareholders in Biocon Biologics Ltd. via a mix of cash and shares in a deal that values the biosimilars unit at $5.5 billion.",
    "url": "https://www.bloomberg.com/news/articles/2025-12-06/biocon-moves-to-fully-own-biologics-unit-valued-at-5-5-billion",
    "published": "2025-12-06T10:38:23+00:00",
    "source": "Bloomberg Markets"
  }
}